Histogen Inc expected to post a loss of 11 cents a share - Earnings Preview

Histogen

09/11/2021 03:06

* Histogen Inc  HSTO.OQ   HSTO.O  is expected to report
results on November 10.
​* Refinitiv's mean analyst estimate for Histogen Inc is for a
loss of 11 cents per share. For the same quarter last year, the
company reported a loss of 27 cents per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Histogen Inc is
$2.7​, about 73% above​ its last closing price of $0.73. ​​​
* Previous quarterly performance (using preferred earnings
measure in US dollars). ​
 QUARTER       STARMINE    REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        SMARTESTIM  IBES                 MET,    SE %
               ATE®        ESTIMATE             MISSED  
 Jun. 30 2021  -0.17       -0.17      -0.10     Beat    41.2
 Mar. 31 2021  -0.15       -0.15      -0.14     Beat    6.7
 Dec. 31 2020  -0.35       -0.35      -0.26     Beat    25.7​
                                      -0.27             
 ​​                                   -1.52             
                                                        ​
                                      -0.80             
 Sep. 30 2019              -1.20      -1.00     Beat    16.7
 This summary was machine generated November 9 at 03:05 GMT.  All
figures in US dollars unless otherwise stated